Reprogramming the male gamete genome: A window to successful gene therapy

Gene

Volumn 234, Issue 1, 1999, Pages 1-9

  Krawetz, S A ^a   Kramer, J A ^a   McCarrey, J R ^b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Cell fate; Commitment; Determination; Gene therapy; Potentiation; Stem cell

Indexed keywords

CELL DIFFERENTIATION; CHROMATIN STRUCTURE; GENE EXPRESSION REGULATION; GENE THERAPY; HEMATOPOIESIS; HUMAN; PRIORITY JOURNAL; REVIEW; SPERMATOGENESIS; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; GENE THERAPY; GENOME; HEMATOPOIESIS; MALE; MICE; SPERMATOGENESIS; SPERMATOZOA;

EID: 0032967471     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00147-X     Document Type: Review

References (70)

1. Ariel M., Cedar H., McCarrey J. Developmental changes in methylation of spermatogenesis-specific genes include reprogramming in the epididymis. Nat. Genet. 7:1994;59-63.
2. Bellvé A.R. Purification, culture and fractionation of spermatogenic cells. Meth. Enzymol. 225:1993;84-113.
3. Bellvé A.R. The male germ cell; origin, migration, proliferation and differentiation. Semin. Cell Dev. Biol. 9:1998;379-391.
4. Bode J., Stengert-Iber M., Kay V., Schlake T., Dietz-Pfeilstetter A. Scaffold/matrix-attached regions: topological switches with multiple regulatory functions. Crit. Rev. Eukaryotic Gene Exp. 6:1996;115-138.
5. Bonifer C. The chicken lysozyme locus as a paradigm for the complex developmental regulation of eukaryotic gene loci. J. Biol. Chem. 272:1997;26057-26078.
6. Bordignon C., Notarangelo L.D., Nobili N., Ferrari G., Casorati G., Panina P., Masso E., Maggioni D., Rossi C., Servida P., Ugazio A.G., Mavillo F. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA immunodeficient patients. Science. 270:1995;470-475.
7. Boyes J., Bird A. DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell. 64:1991;1123-1134.
8. Calzolari R., McMorrow T., Yannoutsos N., Langeveld A., Grosveld F. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and δβ-thalassemia affects β- but not γ-globin gene expression. EMBO J. 18:1999;949-958.
9. Castro M.G. Gene therapy strategies for the treatment of pituitary tumours. J. Mol. Endocrinol. 22:1999;9-18.
10. Chao J., Wang C., Chao L. Gene therapy for hypertension - A review of potential targets. Biodrugs. 11:1999;43-53.
11. Chen H.H., Mack L.M., Kelly R., Ontell M., Kochanek S., Clemens P.R. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA. 94:1997;1645-1650.
12. Choi Y., Aizawa A., Hecht N.B. Genomic analysis of the mouse protamine 1, protamine 2, and transition protein 2 gene cluster reveals hypermethylation in expressing cells. Mamm. Genome. 8:1997;317-323.
13. Dym M. Spermatogonial stem cells of the testis. Proc. Natl. Acad. Sci. USA. 91:1994;11298-11302.
14. Dzierzak E., Medvinsky A. Mouse embryonic hematopoiesis. Trends Genet. 11:1995;359-366.
15. Eden S., Cedar H. Role of DNA methylation in the regulation of transcripton. Curr. Opin. Genet. Dev. 4:1994;255-259.
16. Eden S., Hashimshony T., Keshet I., Cedar H., Thome A.W. DNA methylation models histone acetylation. Nature. 394:1998;842.
17. Evans C.H., Ghivizzani S.C., Kang R., Muzzonigro T., Wasko M.C., Herndon J.H., Robbins P.D. Gene therapy for rheumatic diseases. Arthrit. Rheumat. 42:1999;1-16.
18. Federoff H.J., Atkinson M. Towards gene therapy of neurodegenerative disease. Neuronal Degeneration and Regeneration: from Basic To Prospects for Therapy. Prog. Brain Res. 1998;. 117, 503-510.
19. Flint J., Thomas K., Micklem G., Raynham H., Clark K., Doggett N.A., King A., Higgs D.R. The relationship between chromosome structure and function at a human telomeric region. Nat. Genet. 15:1997;252-257.
20. Gearhart J. New potential for human embryonic stem cells. Science. 282:1998;1061-1062.
21. Geiger H., Sick S., Bonifer C., Muller A.M. Globin gene expression is reprogrammed in chimeras generated by injecting hematopoietic stem cells into mouse blastocysts. Cell. 93:1998;1055-1065.
22. Grosveld F., Boer E., Dillon N., Fraser P., Gribnau J., Milot E., Trimborn T., Wijgerde A. The dynamics of globin expression and gene therapy vectors. Sem. Hematol. 35:1998;105-111.
23. Grunstein M. Histone acetylation in chromatin structure and transcription. Science. 389:1997;349-352.
24. Hall S.J., Chen S.H., Woo S.L.C. The promise and reality of cancer gene therapy. Am. J. Hum. Genet. 61:1997;785-789.
25. Hanscombe O., Whyatt D., Fraser P., Yannoutsos N., Greaves D., Dillon N., Grosveld F. Importance of globin gene order for correct developmental expression. Genes Dev. 5:1991;1387-1394.
26. Hecht N.B. The making of a spermatozoon: a molecular perspective. Dev. Genet. 16:1995;95-103.
27. Higgs D.R. Do LCRs open chromatin domains? Cell. 95:1998;299-302.
28. Higgs D.R., Sharpe J.A., Wood W.G. Semin. Hematol. 35:1998;93-104.
29. Hu M., Krause K., Greaves M., Sharkis S., Dexter M., Heyworth C., Enver T. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:1997;774-785.
30. Imhof A., Wolffe A.P. Transcription: Gene control by targeted histone acetylation. Curr. Biol. 8:1998;R422-R424.
31. Jimemez G., Griffiths S., Ford A.M., Greaves M.F., Enver T. Activation of the β-globin locus control region precedes commitment to the erythroid lineage. Proc. Natl. Acad. Sci. USA. 89:1992;10618-10622.
32. Jones P.L., Veenstra G.J.C., Wade P.A., Vermaak D., Kass S.U., Landsberger N., Stouboulis J., Wolffe A.P. Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet. 19:1998;187-191.
33. Karpati G., Pari G., Molnar M.J. Molecular therapy for genetic muscle diseases - status 1999. Clin. Genet. 55:1999;1-8.
34. Kennedy M., Firpo M., Choi K., Wall C., Robertson S., Kabrun N., Keller G. A common precursor for primitive erythropoiesis and definitive haematopoiesis. Nature. 386:1997;488-493.
35. Kioussis, D., Festenstein, R., 1997. Locus control regions: overcoming heterochromatin-induced gene inactivation in mammals. Curr. Opin. Genet. Dev. 7, 614-619.
36. Kornberg R.D., Lorch Y. Chromatin structure and transcription. Annu. Rev. Cell Biol. 8:1992;563-587.
37. Kramer J.A., Krawetz S.A. Nuclear matrix interactions within the sperm genome. J. Biol. Chem. 271:1996;11619-11622.
38. Kramer J.A., Krawetz S.A. RNA in spermatozoa: Implications for the alternative haploid genome. Mol. Hum. Reprod. 3:1997;473-478.
39. Kramer J.A., McCarrey J.M, Djakiew D., Krawetz S.A. Differentiation: the selective potentiation of chromatin domains. Development. 125:1998;4749-4755.
40. Lawson G.M., Knoll B.J., March C.J., Woo S.L.C., Tsai M.-J., O'Malley B.W. Definition of 5′ and 3′ structural boundaries of the chromatin domain containing the ovalbumin multigene family. J. Biol. Chem. 257:1982;1501-1507.
41. Levine A., Cantoni G.L., Razin A. Inhibition of promoter activity by methylation: possible involvement of protein mediators. Proc. Natl. Acad. Sci. USA. 88:1991;6515-6518.
42. McCarrey J.R, Berg W.M., Paragioudakis S.J., Zhang P.l., Dilworth D.D., Arnold B.l., Rossi J.J. Differential transcription of Pgk genes during spermatogenesis in the mouse. Dev. Biol. 154:1992;160-168.
43. McCarrey J.R. Development of the germ cell. Desjardins C., Ewing L.L. Cell and Molecular Biology of the Testis. 1993;58-89 Oxford University Press, Oxford.
44. McCarrey J.R. Spermatogenesis as a model system for developmental analysis of regulatory mechanisms associated with tissue-specific gene expression. Semin. Cell Dev. Biol. 9:1998;459-466.
45. Martinez-Balbas M.A., Dey A., Rabindran S.K., Ozato K., Wu C. Displacement of sequence-specific transcription factors from mitotic chromatin. Cell. 83:1995;29-38.
46. Mendez M.J., Green L.L., Corvalan J.R.F., Jia X.C., MaynardCurrie C.E., Yang X.D., Gallo M.L., Louie D.M., Lee D.V., Erickson K.L., Luna J., Roy C.M.N., Abderrahim H., Kirschenbaum F., Noguchi M., Smith D.H., Fukushima A., Hales J.F., Finer M.H., Davis C.G., Zsebo K.M., Jakobovits A. Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in mice. Nat. Genet. 15:1997;146-156.
47. Michelotti E.F., Sanford S., Levens D. Marking of active genes on mitotic chromosomes. Nature. 388:1997;895-899.
48. Milot E., Strouboulis J., Trimborn T., Wijgerde M., Boer E., Langeveld A., Tanun K., Vergeer W., Yannoutsos N., Grosveld F., Fraser P. Heterochromatin effects on the frequency and duration of LCR-mediated gene transcription. Cell. 87:1996;105-114.
49. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 8:1993;2844-2853.
50. O'Prey J., Harrison P.R. Tissue-specific regulation of the rabbit 15-lipoxygenase gene in erythroid-cells by a transcriptional silencer. Nucleic Acids Res. 23:1995;3664-3672.
51. Palu G., Bonaguro R., Marcello A. In pursuit of new developments for gene therapy of human diseases. J. Biotechnol. 68:1999;1-13.
52. Pazin M.J., Kadonaga J. What's up and down with histone deacetylation and transcription? Cell. 89:1997;325-328.
53. Peterson K.R., Navas P.A., Li Q.L., Stamatoyannopoulos G. LCR-dependent gene expression in beta-globin YAC transgenics: detailed structural Studies validate functional analysis even in the presence of fragmented YACs. Hum. Mol. Genet. 7:1998;2079-2088.
54. Piechaczek C., Fetzer C., Baiker A., Bode J., Lipps H.J. A vector based on the SV40 origin of replication and chromosomal S/MARs replicates episomally in CHO cells. Nucleic Acids Res. 27:1999;426-428.
55. Razin A., Kafri T. DNA methylation from embryo to adult. Prog. Nucleic Acids Res. Mol. Biol. 48:1994;53-81.
56. Reik A., Telling A., Zitnik G., Cimbora D., Epner E., Groudine M. The locus control region is necessary for gene expression in the human β-globin locus but not the maintenance of an open chromatin structure in erythroid cells. Mol. Cell. Biol. 18:1998;5992-6000.
57. Sadelain M., Wang Chj., Antoniou M., Grosveld F., Mulligan R.C. Generation of a high-titer retroviral vector capable of expressing high-levels of the human beta-globin gene. Proc. Natl. Acad. Sci. USA. 92:1995;6728-6732.
58. Sassone-Corsi P. Transcriptional checkpoints determining the fate of male germ cells. Cell. 88:1997;163-166.
59. Segil N., Guermah M., Hoffman A., Roeder R.G., Heintz N. Mitotic regulation of TFIID: Inhibition of activator-dependent transcription and changes in subcellular localization. Genes Dev. 10:1996;2389-2400.
60. Smith C.L., Hager G.L. Transcriptional regulation of mammalian genes in vivo: a tale of two templates. J. Biol. Chem. 272:1997;27493-27496.
61. Stalder J., Larsen A., Engel J.D., Dolan M., Groudine M., Weintraub H. Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNase I. Cell. 20:1980;451-460.
62. Thomsom J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Jones J.M. Embryonic stem cell lines derived from human blastocysts. Science. 282:1998;1145-1147.
63. Verma I.M., Somia N. Gene therapy - promises, problems and prospects. Nature. 309:1997;239-242.
64. Wakayama T., Perry A.C.F., Zuccotti M., Johnson K.R., Yanagimachi R. Full-term development of mice from enucleated oocytes injected with cumulus cell nuclei. Nature. 394:1998;369-374.
65. Walter W.R., Singh G.B., Krawetz S.A. MARs mission update. Biochem. Biophys. Res. Commun. 242:1998;419-422.
66. Weihl C., Macdonald R.L., Stoodley M., Luders J., Lin G. Gene therapy for cerebrovascular disease. Neurosurgery. 44:1999;239-252.
67. Weintraub H., Groudine M. Chromosomal subunits in active genes have an altered conformation. Science. 193:1976;848-856.
68. Wilmut I., Schnieke A.E., McWhir J., Kind A.J., Campbell K.H.S. Viable offspring derived from fetal and adult mammalian cells. Nature. 385:1997;810-813.
69. Yuh C.H., Bolouri H., Davidson E.H. Genomic cis-regulatory logic: experimental and computational analysis of a sea urchin gene. Science. 270:1998;1896-1902.
70. Zhang L.P., Stroud J.C., Walter C.A., Adrian G.S., McCarrey J.R. A gene-specific promoter in transgenic mice directs testis-specific demethylation prior to transcriptional activation in vivo. Biol. Reprod. 59:1998;284-292.